Diana Lenzner

1.4k total citations
23 papers, 1.1k citations indexed

About

Diana Lenzner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Diana Lenzner has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Diana Lenzner's work include Lung Cancer Treatments and Mutations (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Immune Cell Function and Interaction (3 papers). Diana Lenzner is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Immune Cell Function and Interaction (3 papers). Diana Lenzner collaborates with scholars based in United States, Switzerland and Poland. Diana Lenzner's co-authors include Stephanie R. Land, Anil V. Parwani, Athanassios Argiris, Rohtesh S. Mehta, Jonas T. Johnson, Theresa L. Whiteside, Jill M. Siegfried, Mirosław J. Szczepański, Marta Szajnik and Laura P. Stabile and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Diana Lenzner

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diana Lenzner United States	18	539	301	249	225	171	23	1.1k
Trevor E. Angell United States	27	647 1.2×	401 1.3×	229 0.9×	160 0.7×	336 2.0×	75	2.2k
Xiao-Jun Wu China	18	625 1.2×	268 0.9×	286 1.1×	118 0.5×	47 0.3×	35	1.2k
Polly Niravath United States	14	456 0.8×	76 0.3×	195 0.8×	209 0.9×	151 0.9×	53	970
G. Henze Germany	22	436 0.8×	130 0.4×	350 1.4×	115 0.5×	41 0.2×	50	1.7k
Diane Savarese United States	16	576 1.1×	101 0.3×	274 1.1×	526 2.3×	56 0.3×	24	1.2k
Yohei Horikawa Japan	22	341 0.6×	205 0.7×	931 3.7×	385 1.7×	83 0.5×	70	1.6k
Amit Panwalkar United States	13	1.5k 2.8×	338 1.1×	338 1.4×	1.0k 4.5×	83 0.5×	29	2.0k
Kaoru Niimi Japan	20	338 0.6×	182 0.6×	478 1.9×	524 2.3×	40 0.2×	101	1.7k
Kari G. Chaffee United States	21	726 1.3×	306 1.0×	441 1.8×	144 0.6×	197 1.2×	43	1.8k
Marek Pudełko Poland	16	920 1.7×	117 0.4×	255 1.0×	160 0.7×	85 0.5×	42	1.3k

Countries citing papers authored by Diana Lenzner

Since Specialization

Citations

This map shows the geographic impact of Diana Lenzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Lenzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Lenzner more than expected).

Fields of papers citing papers by Diana Lenzner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Lenzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Lenzner. The network helps show where Diana Lenzner may publish in the future.

Co-authorship network of co-authors of Diana Lenzner

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Lenzner. A scholar is included among the top collaborators of Diana Lenzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Lenzner. Diana Lenzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volz, Conrad D., Drew R. Michanowicz, Kyle Ferrar, et al.. (2013). A study of parabens and bisphenol A in surface water and fish brain tissue from the Greater Pittsburgh Area. Ecotoxicology. 22(4). 632–641. 58 indexed citations

Austin, Frances, Arun Mavanur, Magesh Sathaiah, et al.. (2012). Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms. Annals of Surgical Oncology. 19(5). 1386–1393. 57 indexed citations

Szajnik, Marta, Mirosław J. Szczepański, Esther Elishaev, et al.. (2012). 17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma. Gynecologic Oncology. 127(3). 587–594. 25 indexed citations

Steinman, Richard A., Qiong Yang, Maura Gasparetto, et al.. (2012). Deletion of the RNA‐editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice. International Journal of Cancer. 132(8). 1741–1750. 33 indexed citations

Foon, Kenneth A., Suzanne Lentzsch, Patricia Kropf, et al.. (2012). Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia. Blood. 119(13). 3184–3185. 34 indexed citations

Feinstein, Trevor, Stephen Y. Lai, Diana Lenzner, et al.. (2011). Prognostic factors in patients with high‐risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head & Neck. 33(3). 318–323. 34 indexed citations

Linkov, Faina, G. Larry Maxwell, Ashley S. Felix, et al.. (2011). Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: Implications for cancer risk reduction. Gynecologic Oncology. 125(1). 114–119. 31 indexed citations

Budiu, Raluca A., Gina Mantia-Smaldone, Esther Elishaev, et al.. (2011). Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer. Cancer Immunology Immunotherapy. 60(7). 975–984. 48 indexed citations

Mehta, Rohtesh S., Diana Lenzner, & Athanassios Argiris. (2011). Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study. Annals of Surgical Oncology. 19(3). 722–727. 60 indexed citations

10.

Stabile, Laura P., Sanja Đačić, Stephanie R. Land, et al.. (2010). Combined Analysis of Estrogen Receptor β-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome. Clinical Cancer Research. 17(1). 154–164. 129 indexed citations

11.

Malini, S., Anil V. Parwani, Pamela A. Hershberger, Diana Lenzner, & Joel L. Weissfeld. (2010). Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. The Journal of Steroid Biochemistry and Molecular Biology. 123(1-2). 30–36. 65 indexed citations

12.

Stabile, Laura P., Mary E. Rothstein, Phouthone Keohavong, et al.. (2010). Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice. Cancers. 2(4). 2153–2170. 31 indexed citations

13.

Mandapathil, Magis, Mirosław J. Szczepański, Marta Szajnik, et al.. (2009). Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer. Clinical Cancer Research. 15(20). 6348–6357. 152 indexed citations

14.

Fourcade, Julien, Pavol Kudela, Zhaojun Sun, et al.. (2009). PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients. The Journal of Immunology. 182(9). 5240–5249. 131 indexed citations

15.

Bao, Philip, Douglas M. Potter, David P. Eisenberg, et al.. (2009). Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma. HPB. 11(7). 606–611. 18 indexed citations

16.

Vlad, Anda, Raluca A. Budiu, Diana Lenzner, et al.. (2009). A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer. Cancer Immunology Immunotherapy. 59(2). 293–301. 54 indexed citations

17.

Brell, Joanna M., Khalid Matin, Terry Evans, et al.. (2009). Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer. Oncology. 76(4). 270–274. 29 indexed citations

18.

Zhang, Guangfeng, Xuwan Liu, Adam M. Farkas, et al.. (2008). Estrogen Receptor β Functions through Nongenomic Mechanisms in Lung Cancer Cells. Molecular Endocrinology. 23(2). 146–156. 99 indexed citations

19.

Chatta, Gurkamal, Trevor Feinstein, Leonard J. Appleman, et al.. (2008). Oxaliplatin and docetaxel in castration-resistant prostate cancer (CRPC) patients treated with up to two prior chemotherapeutic regimens: Updated results of a phase II trial. Journal of Clinical Oncology. 26(15_suppl). 5148–5148. 5 indexed citations

20.

Lenzner, Diana. (2007). ARE TISSUES OF CHANNEL CATFISH MORE ESTROGENIC IN AREAS WITH HIGH DENSITIES OF COMBINED SEWAGE OVERFLOWS. D-Scholarship@Pitt (University of Pittsburgh). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact